Home
Conditions
Tauopathies

Clinical trial condition

Tauopathies

Explore clinical trials studying Tauopathies. Study availability and eligibility vary by location and protocol.

20 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Tauopathies trial results

Completed

Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems

NCT05080777

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: UConn Health (Geriatrics Associates) Farmington, Connecticut, United States

Emory HealthCare (IMCC) Atlanta, Georgia, United States

View Trial Details

Completed

CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease

NCT03938870

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +11 more
Locations: Washington University in Saint Louis St Louis, Missouri, United States

View Trial Details

Completed

Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers

NCT05202223

Conditions: Alzheimer Disease, Behavior, Behavioral Symptoms, +10 more
Locations: University of Kentucky Lexington, Kentucky, United States

View Trial Details

Completed

A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population

NCT05527288

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831

NCT03538522

Conditions: Alzheimer Dementia, Alzheimer Disease, Arterial Occlusive Diseases, +27 more
Locations: NeuroActiva-Clinical Research Unit Auckland, New Zealand

NeuroActiva Testing Facility of NeuroActiva (New Zealand) Ltd Auckland, New Zealand

View Trial Details

Completed

Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations

NCT02676843

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +13 more
Locations: Morton A. Kreitchman PET Center New York, United States

View Trial Details

Completed

A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Intravenously Administered BMS-986168 in Healthy Subjects

NCT02294851

Conditions: Nervous System Diseases, Neurodegenerative Diseases, Tauopathies
Locations: WCCT Global, LLC Cypress, California, United States

Covance Clinical Research Unit Inc. Dallas, Texas, United States

View Trial Details

Completed

Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects

NCT02103894

Conditions: Alzheimer Disease, Alzheimer's Disease (AD), Basal Ganglia Diseases, +40 more
Locations: Molecular NeuroImaging, LLC New Haven, Connecticut, United States

View Trial Details

Completed

COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE

NCT02860338

Conditions: Alzheimer Disease, Alzheimer's Disease, Amino Acid Metabolism, Inborn Errors, +62 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

NCT05508789

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
Locations: Hospital Italiano de Buenos Aires ABB, Argentina

Clinica Privada Banfield Banfield, Argentina

Fundación para el Estudio y Tratamiento de Enfermedades Mentales (FETEM) Buenos Aires, Argentina

Stat Research S.A. Buenos Aires, Argentina

View all 141 locations

View Trial Details

Tauopathies

Tauopathies trial results

Related conditions